Metabolic syndrome as a risk factor for Alzheimer's disease: Is Aβ a crucial factor in both pathologies?

Campos-Peña, Victoria, Toral-Rios, Danira, Becerril-Pérez, Fernando, Sánchez-Torres, Carmen, Delgado-Namorado, Yair, Torres-Ossorio, Elimar, Franco-Bocanegra, Diana, Carvajal, Karla·2017·Antioxidants & Redox Signaling

Cites (232)

Items 201–232 of 232

  1. Soluble amyloid precursor protein-α rescues age-linked decline in neural progenitor cell proliferation
    Michael P. Demars, Carolyn Hollands, Kai Zhao, Orly Lazarov · 2013 · Neurobiology of Aging
  2. Chapter 22 Structure, Function, and Regulation of Insulin‐Degrading Enzyme
    Raymond E. Hulse, Luis Abel Ralat, Tang Wei‐Jen · 2009 · Vitamins and hormones
  3. Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders
    ZOFIA BŁACH-OLSZEWSKA, Jerzy Leszek · 2007 · Neuropsychiatric Disease and Treatment
  4. Molecular basis for the thiol sensitivity of insulin-degrading enzyme
    Marie Neant-Fery, Rubén D. Garcia-Ordoñez, Todd P. Logan, Dennis J. Selkoe, Lilin Li, Lael Suzanne Reinstatler, Malcolm A. Leissring · 2008 · Proceedings of the National Academy of Sciences
  5. The contribution of astrocytes to Alzheimer's disease
    Amy M. Birch · 2014 · Biochemical Society Transactions
  6. Alzheimer's disease: brain expression of a metabolic disorder?
    Sara Merlo, Simona Federica Spampinato, Pier Luigi Canonico, Agata Copani, Maria Angela Sortino · 2010 · Trends in Endocrinology and Metabolism
  7. Acute effect of the dual angiotensin‐converting enzyme and neutral endopeptidase 24‐11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat
    Valérie Arbin, Nicole Claperon, M.-C. Fournié-Zaluski · 2001 · British Journal of Pharmacology
  8. Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases
    Maurizio Gasperi, Castellano Ae · 2010 · Journal of Endocrinological Investigation
  9. beta-Amyloid neurotoxicity.
    Gianluigi Forloni · 1993 · PubMed
  10. Two measures of insulin sensitivity provided similar information in a U.S. population
    Dawn M. Bravata, Carolyn K. Wells, John Concato, Walter N. Kernan, Lawrence M. Brass, Barbara Gulanski · 2004 · Journal of Clinical Epidemiology
  11. Amyloid <i>β</i> 1-42 Induces Hypometabolism in Human Stem Cell-Derived Neuron and Astrocyte Networks
    Tarczyluk, Marta A, Nagel, David A, Parri, H Rhein, Tse, Erin HY, Brown, James E, Coleman, Michael D, Hill, Eric J · 2015 · Journal of Cerebral Blood Flow &amp; Metabolism
  12. A cDNA for a human microtubule associated protein 2 epitope in the Alzheimer neurofibrillary tangle
    Rachael L. Neve, Dennis J. Selkoe, David M. Kurnit, Kenneth S. Kosik · 1986 · Molecular Brain Research
  13. Role of insulin resistance in Alzheimer’s disease
    Zhiyou Cai, Ming Xiao, Liying Chang, Liang‐Jun Yan · 2014 · Metabolic Brain Disease
  14. Targeting the Wnt/frizzled signaling pathway after myocardial infarction: A new tool in the therapeutic toolbox?
    Evangelos P. Daskalopoulos, Kevin C.M. Hermans, Ben J. Janssen, W. Matthijs Blankesteijn · 2012 · Trends in Cardiovascular Medicine
  15. Neurobiology of the metabolic syndrome: An allostatic perspective
    Gertjan van Dijk, Bauke Buwalda · 2008 · European Journal of Pharmacology
  16. Effects of Dual Angiotensin-Converting Enzyme and Neutral Endopeptidase 24-11 Chronic Inhibition by Mixanpril on Insulin Sensitivity in Lean and Obese Zucker Rats
    Valérie Arbin, Nicole Claperon, Marie‐Claude Fournié‐Zaluski, Bernard Pierre Roques, J. Peyroux · 2003 · Journal of Cardiovascular Pharmacology
  17. New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset Obesity
    Matthias Becker, Wolf‐Eberhard Siems, Reinhart Kluge, Florian Gembardt, Heinz‐Peter Schultheiss, Michael Schirner, Thomas Walther · 2010 · PLoS ONE
  18. Along the way to a neurofibrillary tangle: a look at the structure of tau
    Kosik, Kenneth S., Kowall, Neil W., McKee, Ann · 1989 · Annals of Medicine
  19. Vascular risk factors, alcohol intake, and cognitive decline
    Francesco Panza, Cristiano A. Capurso, Alessia D’Introno, Anna Maria Colacicco, Vincenza Frisardi, Andrea Santamato, Maurizio Ranieri, Pietro Fiore, Gianluigi Vendemiale, Davide Seripa et al. · 2008 · The journal of nutrition health & aging
  20. Angiotensin-Converting Enzyme as a Potential Target for Treatment of Alzheimer's Disease: Inhibition or Activation?
    Kun Zou, Makoto Michikawa · 2008 · Reviews in the Neurosciences
  21. The Skeletal Muscle Wnt Pathway May Modulate Insulin Resistance and Muscle Development in a Diet‐Induced Obese Rat Model
    Dan Zhou, Rita S. Strakovsky, Xiyuan Zhang, Yuan‐Xiang Pan · 2012 · Obesity
  22. Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues
    Oliver Schmitt · 1998 · International Journal of Molecular Medicine
  23. Amyloid β: Walking on the dark side of the moon
    Ernesto Fedele, Daniela Rivera, Barbara Marengo, Maria Adelaide Pronzato, Roberta Ricciarelli · 2015 · Mechanisms of Ageing and Development
  24. Evaluation of inflammation-related genes polymorphisms in Mexican with Alzheimer’s disease: a pilot study
    Danira Toral-Ríos, Diana Franco-Bocanegra, Óscar Rosas‐Carrasco, Francisco Mena‐Barranco, Rosa Carvajal-García, Marco Antonio Meraz‐Ríos, Victoria Campos‐Peña · 2015 · Frontiers in Cellular Neuroscience
  25. Tau protein and the paired helical filament of Alzheimer's disease.
    M. Goedert, A. Klug · 1999 · Brain Research Bulletin
  26. Connecting Type 2 diabetes to Alzheimer’s disease
    Fernanda G. De Felice · 2013 · Expert Review of Neurotherapeutics
  27. The effect of orexins on intestinal motility in vitro in fed and fasted rats.
    W. Korczyński, Michal CEREGRZYN, I Kato · 2006 · PubMed
  28. Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
    Engelhart, Marianne J., Geerlings, Mirjam I., Meijer, John, Kiliaan, Amanda, Ruitenberg, Annemieke, van Swieten, John C., Stijnen, Theo, Hofman, Albert, Witteman, Jacqueline C. M., Breteler, Monique M. B. · 2004 · Archives of Neurology
  29. Analysis of the beta-amyloid protein precursor of Alzheimer's disease: mRNAs and protein products.
    Mark R. Palmert, Marcia Berman Podlisny, Todd Eliot Golde, Mark L. Cohen, D M Kovacs, Rudolph E. Tanzi, James F. Gusella, Peter John Whitehouse, D. S. Witker, Tilman Oltersdorf · 1990 · PubMed
  30. Expression of β-site APP-cleaving enzyme 1 in the hippocampal tissue of an insulin-resistant rat model of Alzheimer's disease
    Shize Li, NINI WANG, Jiyu Lou · 2015 · Experimental and Therapeutic Medicine
  31. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Lövestam-Adrian · 1997 · Research Portal (Queen's University Belfast)
  32. Untitled work
    Cole · 2000 · 10.1002/1097-0029(20000815)50:4